Lan G. Coffman

Lan Coffman practices at WVU Medicine Wheeling Hospital in Wheeling, West Virginia, part of West Virginia University Health System.

Lan Coffman's NPI, 1104144039, was assigned on May 17, 2010. Lan Coffman holds Michigan license 4301096200.

Lan Coffman's primary practice is WVU Medicine Wheeling Hospital, at 1 Medical Park, Wheeling, WV 26003 in Ohio County. The practice phone is (304) 243-3000.

Lan Coffman's primary practice is WVU Medicine Wheeling Hospital in Wheeling, West Virginia, part of West Virginia University Health System. Lan Coffman is also affiliated with University Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Lan Coffman to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lan Coffman practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Lan Coffman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Lan Coffman is board certified in medical oncology by the American Board of Internal Medicine. Lan Coffman is licensed in Michigan.

CMS data shows 86 Medicare services from Lan Coffman across 2 procedure codes in 2022, for 17 Medicare patients. Medicare paid $6,856 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 17 Medicare patients who saw Lan Coffman in 2024. 65% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lan Coffman's median patient age at 72, with 83% women.

In 2024, Lan Coffman wrote 91 Medicare Part D claims for 15 patients. 91% of them were for generic drugs. CMS names the drug for 41 of them, across 2 drugs with 11 or more claims each, at $782 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Lan Coffman for performance year 2024, reported as part of a group. Lan Coffman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lan Coffman as offering telehealth.

CMS Open Payments shows 4 general payments to Lan Coffman from 2 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 91% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,100.